A retrospective review of 633 adults and children who underwent bioprosthetic pulmonary valve replacement (PVR) for congenital heart disease between 1996 and 2014 indicated that the risk of re-intervention was five times greater for children than adults. In addition, the likelihood of re-intervention decreased by 10 percent for each increasing year of age at surgery. Valve type was another important determinant of re-intervention, according to Rio S. Nomoto, BA, medical student at Tufts University School of Medicine, who presented the results of this research at the 95th American Association for Thoracic Surgery (AATS) Annual Meeting in Seattle on April 28.